- Home
- RNA vs KRC Comparison
RNA vs KRC Comparison
Compare RNA & KRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$72.39
HOLD
Current Price
$39.85
Company Overview
Basic Information| Metric | RNA | KRC |
|---|---|---|
| Founded | 2012 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.4B |
| IPO Year | 2020 | 1997 |
Fundamental Metrics
Financial Performance| Metric | RNA | KRC |
|---|---|---|
| Price | $72.39 | $39.85 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 20 | 13 |
| Target Price | ★ $69.26 | $41.75 |
| AVG Volume (30 Days) | ★ 2.1M | 1.5M |
| Earning Date | 02-26-2026 | 02-09-2026 |
| Dividend Yield | N/A | ★ 5.42% |
| EPS Growth | N/A | ★ 62.23 |
| EPS | N/A | ★ 2.71 |
| Revenue | $20,868,000.00 | ★ $1,126,859,000.00 |
| Revenue This Year | $57.30 | N/A |
| Revenue Next Year | $28.41 | $4.23 |
| P/E Ratio | ★ N/A | $14.70 |
| Revenue Growth | ★ 106.27 | 0.77 |
| 52 Week Low | $21.51 | $27.07 |
| 52 Week High | $72.61 | $45.03 |
Technical Indicators
Market Signals| Indicator | RNA | KRC |
|---|---|---|
| Relative Strength Index (RSI) | 73.95 | 55.34 |
| Support Level | $72.04 | $38.08 |
| Resistance Level | $72.47 | $40.20 |
| Average True Range (ATR) | 0.21 | 0.85 |
| MACD | -0.21 | 0.31 |
| Stochastic Oscillator | 63.71 | 95.69 |
Price Performance
Historical Comparison RNA
KRC
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
About KRC Kilroy Realty Corporation
Kilroy Realty is a premier owner and landlord of approximately 17 million square feet of office space across Los Angeles, San Diego, the San Francisco Bay Area, Austin, Texas, and greater Seattle. The company operates as a real estate investment trust.